|Articles|December 8, 2016
New CEO for Muse bio
December 08, 2016
Advertisement
Muse bio (Boulder, CO) announced that Dr. Kevin Ness has been appointed Chief Executive Officer and member of the Board of Directors.
Prior to joining Muse bio, Dr. Ness was co-founder, Chief Technology Officer and Chief Operating Officer of 10X Genomics. Previously, he co-founded and was Vice President of Product Development at QuantaLife, acquired by Bio-RAD in 2011.
He succeeds Muse bio's founding CEO Ryan Gill, who becomes the company's Chief Science Officer.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
2
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
3
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
4
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
5